Jushi (OTCMKTS:JUSHF – Get Free Report) and IceCure Medical (NASDAQ:ICCM – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk and profitability.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Jushi and IceCure Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Jushi | 0 | 0 | 1 | 0 | 3.00 |
| IceCure Medical | 1 | 1 | 2 | 0 | 2.25 |
IceCure Medical has a consensus target price of $30.00, indicating a potential upside of 2,701.12%. Given IceCure Medical’s higher probable upside, analysts clearly believe IceCure Medical is more favorable than Jushi.
Risk and Volatility
Jushi has a beta of -0.61, meaning that its stock price is 161% less volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500.
Insider and Institutional Ownership
21.7% of Jushi shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 23.1% of Jushi shares are owned by company insiders. Comparatively, 2.4% of IceCure Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Jushi and IceCure Medical”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Jushi | $262.91 million | 0.32 | -$68.59 million | ($0.28) | -1.48 |
| IceCure Medical | $3.38 million | 1.09 | -$15.06 million | ($8.52) | -0.13 |
IceCure Medical has lower revenue, but higher earnings than Jushi. Jushi is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Jushi and IceCure Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Jushi | -19.98% | N/A | -12.91% |
| IceCure Medical | -427.67% | -174.26% | -112.58% |
Summary
Jushi beats IceCure Medical on 8 of the 14 factors compared between the two stocks.
About Jushi
Jushi Holdings Inc. is a U.S. cannabis company focused on cultivating, processing and selling cannabis products. Its business includes cultivation and manufacturing facilities as well as retail dispensaries serving medical and adult-use customers in markets where cannabis sales are permitted. The company’s product portfolio has included flower, concentrates, vapes and other cannabis products sold under brands such as The Bank, The Lab and Sèchè. Its retail operations have included the Beyond Hello dispensary brand.
About IceCure Medical
IceCure Medical Ltd. is an Israel-based medical technology company that develops and commercializes minimally invasive cryoablation systems. Its technology uses liquid nitrogen to freeze and destroy targeted tissue, offering a percutaneous approach to treating tumors. The company’s ProSense system is designed for image-guided cryoablation and is used in procedures involving breast, kidney, lung, bone and other tumors. IceCure also offers the IceSense3 system for treating benign breast fibroadenomas.
Receive News & Ratings for Jushi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jushi and related companies with MarketBeat.com's FREE daily email newsletter.
